BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 108,229 Value ($000) $1 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 190,294 Value ($000) $1 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 111,467 Value ($000) $1 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 278,552 Value ($000) $2 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 164,484 Value ($000) $1 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 285,588 Value ($000) $2 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 363,838 Value ($000) $2 Avg Close $5.52 Range $4.03 - $6.99
Q4 2023
Shares 178,769 Value ($000) $1 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 191,527 Value ($000) $1 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 71,532 Value ($000) $1 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 153,718 Value ($000) $1 Avg Close $9.63 Range $7.82 - $12.08
Q3 2022
Shares 19,121 Value ($000) $241 Avg Close $12.87 Range $10.33 - $15.43
Q3 2021
Shares 41,116 Value ($000) $591 Avg Close $15.77 Range $14.00 - $18.48
Q1 2021
Shares 80,197 Value ($000) $816 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 10,500 Value ($000) $78 Avg Close $5.16 Range $3.36 - $8.99
Q2 2020
Shares 39,599 Value ($000) $189 Avg Close $3.99 Range $1.80 - $6.29
Q1 2020
Shares 138,664 Value ($000) $277 Avg Close $2.75 Range $1.58 - $4.35
Q1 2019
Shares 40,383 Value ($000) $329 Avg Close $8.56 Range $7.10 - $9.95
Q3 2017
Shares 13,086 Value ($000) $69 Avg Close $5.12 Range $3.95 - $6.22
Q4 2014
Shares 35,350 Value ($000) $430 Avg Close $11.05 Range $9.02 - $13.28
Q3 2014
Shares 54,674 Value ($000) $535 Avg Close $12.26 Range $9.78 - $14.62